DYNT: Dynatronics Corporation Growth-Adjusted Market Cap to Net Income
Dynatronics Corporation (DYNT) is managed by industry experts who ensure transparency and strict compliance. This PEG chart on the GURU.Markets system illustrates valuation dynamics, where the value 0.00 reflects the current figure. The business generates revenue from supplying rehabilitation equipment to clinics and athletes; however, fierce competition and budget constraints limit pricing power, keeping margins low.
Dynatronics Corporation (DYNT) - metric breakdowns and financial figures
- current price and projected stock value:
- market capitalization information:
- company book value details:
- business debt structure and liquidity details:
Debt to Equity Ratio Dynatronics Corporation|DYNT - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital dynatronics.com|DYNT - Company Debts|Debt to Book Value Dynatronics Corp.|DYNT - Company Long-Term Debts|Short-Term Debt Dynatronics|Immediate Liquidity Ratio dynatronics.com
- earnings and valuation multiples indicators:
DYNT - Net Profit|Company Profit Forecast Dynatronics Corporation|DYNT - P/E Multiple|Projected Price to Earnings dynatronics.com|DYNT - PEG Multiple|EV/EBITDA Multiple Dynatronics Corp.|DYNT - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Dynatronics|DYNT - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months dynatronics.com|DYNT - Earnings growth in current year|Expected net earnings per share growth next year Dynatronics Corporation
Fundamental company analysis:DYNT (Dynatronics Corp)
Moderate cyclicality in demand for Dynatronics Corporation (DYNT) rehabilitation equipment makes profit stability a key valuation factor. Analyzing the company's PEG ratio, an investor observes a balance between the P/E multiple and earnings growth: values below one signal that the asset is undervalued relative to business expansion, allowing for the identification of potentially high-yield securities.
Competing companies
Price/Earnings to Growth Ratio BSX (Boston Scientific Corp)|PEG Multiple EW (Edwards Lifesciences Corp)|Growth-Adjusted Market Cap to Net Income ResMed Corporation (RMD)|PODD: Price/Earnings to Growth Multiple|Market Cap to Earnings and Growth Ratio ZBH|COO: PEG Multiple|Price to Earnings Adjusted for Growth Rate Invisalign (ALGN)|GMED (Globus Medical Corp) - PEG Multiple|Growth-Adjusted P/E Ratio TMDX (transmedics.com)|Price/Earnings to Growth Multiple ATEC (Alphatec Holdings, Inc.)|AORT (artivion.com) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Enovis ENOV|IART - Price/Earnings to Growth Multiple|Motiva - PEG Multiple|Price to Earnings Adjusted for Growth Rate iLet Bionic Pancreas|IRMD: PEG Multiple|Growth-Adjusted P/E Ratio EMBC|TNDM (Tandem Diabetes Care, Inc.) - PEG Multiple|AxoGen Inc (AXGN) - Growth-Adjusted Market Cap to Net Income|PEG Multiple SIBN|Price/Earnings to Growth Multiple Orthofix Corp OFIX|PEG Multiple BVS (Bioventus Inc.)|PEG Multiple OrthoPediatrics Corp KIDS|TMCI - Price/Earnings to Growth Ratio|SRTA: Price/Earnings to Growth Ratio|CARL (Carlsmed Corp) - Price/Earnings to Growth Multiple|RxSight Ophthalmic - Growth-Adjusted Payback Ratio|CLPT (ClearPoint Neuro Inc.) - PEG Multiple|Price to Earnings Adjusted for Growth Rate stereotaxis.com STXS|Price/Earnings to Growth Ratio Neuronetics (STIM)|Sight Sciences Inc. (SGHT) - Price to Net Income Growth Ratio|Orchestra BioMed - Price/Earnings to Growth Multiple|PEG Multiple Anika Therapeutics Inc. ANIK|InspireMD, Inc. - PEG Multiple|Growth-Adjusted Market Cap to Net Income Jin Medical International ZJYL|vivani.com (VANI) - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio XTNT (Xtant Medical)|Price/Earnings to Growth Ratio NeuroOne Corp|Price/Earnings to Growth Multiple Modular Med (MODD)|PEG Multiple MYO|COCH - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Vivos Therapeutics, Inc. VVOS|NVNO: Growth-Adjusted P/E Ratio|SINT: Price/Earnings to Growth Multiple|Tenon Medical Inc - Company Value to Earnings Growth Ratio|LFWD: PEG Multiple|Growth-Adjusted P/E Ratio AMIX|Price/Earnings to Growth Multiple IVF|Price to Earnings Adjusted for Growth Rate Bone Biologics Corp. BBLG|Price/Earnings to Growth Ratio Axonics Modulation Technologies (AXNX)|Biolase Inc. - Growth-Adjusted P/E Ratio|PEG Multiple FNA (Paragon 28)|PEG Multiple INVO Bioscience Inc. INVO
